[1]
T. S. Emaran Sheikh Ismail, C. Bhangale, J. Ramanand, and H. Mahajan, “Clinical outcome and toxicity in post-COVID suspected cases of mucormycosis treated with amphotericin B at dedicated COVID hospital: a prospective observational study”, Int J Basic Clin Pharmacol, vol. 10, no. 11, pp. 1271–1275, Oct. 2021.